NDC | 52959-593-50 |
Set ID | 4cf69ae7-0c43-4752-b58c-a2052e39b3fa |
Category | HUMAN PRESCRIPTION DRUG LABEL |
Packager | H.J. Harkins Company, Inc. |
Generic Name | |
Product Class | |
Product Number | |
Application Number |
- SPL UNCLASSIFIED SECTION
-
DESCRIPTION
Each 1.0 mL supplies: Percentage of U.S. Recommended Daily Allowance Children 6 mos to 4 years old Vitamin A (as Vitamin A palmitate) 1500 IU 60% Vitamin C (as Ascorbic Acid) 35 mg 88% Vitamin D (as Cholecalciferol) 400 IU 100% Vitamin E (as D-Alpha-Tocopheryl Acid Succinate) 5 IU 50% Vitamin B1 (as Thiamine HCl) 0.5 mg 71% Vitamin B2 (as Riboflavin Phosphate Sodium) 0.6 mg 75% Vitamin B12 (as Cyanocobalamine) 2 mcg 67% Niacin (as Niacinamide) 8 mg 89% Vitamin B6 (as Pyridoxine HCl) 0.4 mg 57% Fluoride (as Sodium Fluoride) 0.25 mg * * Daily Value not established See INDICATIONS AND USAGE section for use by children 6 months to 6 years of age. This product does not contain the essential vitamin folic acid. Active ingredient for caries prophylaxis: Fluoride as sodium fluoride. Does not contain folic acid.
Other ingredients: Caramel color, cherry flavor, ferrous sulfate, oil of orange, glycerin, methylparaben, polysorbate 80, purified water, sodium benzoate and sodium hydroxide.
-
CLINICAL PHARMACOLOGY
It is well established that fluoridation of water supply (1 ppm fluoride) during the period of tooth development leads to a significant decrease in the incidence of dental caries.
Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal, fluorapatite.
The reaction may be expressed by the equation:1
Ca10(PO4)6(OH)2 + 2F- CA10(PO4)6F2 + 2OH-
(Hydroxyapatite) (Fluorapatite)
Three stages of fluoride deposition in tooth enamel can be distinguished:
1. Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed.2. After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted.
3. After eruption, the surface enamel acquires fluoride from water, food, supplementary fluoride and smaller amounts from saliva.
-
INDICATIONS AND USAGE
Supplementation of the diet with vitamins A, C and D.
Multi-Vitamin Fluoride Drops 0.25 mg also provide fluoride for caries prophylaxis.The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.
The American Academy of Pediatrics recommend that infants and young children 6 months to 3 years of age, in areas where drinking water contains less than 0.3 ppm of fluoride, and children 3-6 years of age, in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride, receive 0.25 mg of supplemental fluoride daily which is provided in a dose of 1 mL of Multi-Vitamin Fluoride 0.25 mg drops. (see Dosage and Administration).
Multi-Vitamin Fluoride 0.25 mg drops supply significant amounts of vitamins A, C and D to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain essential vitamins and fluoride.
- WARNINGS
-
PRECAUTIONS
The suggested dose should not be exceeded since dental fluorosis may result from continued ingestion of large amounts of fluoride.
When prescribing vitamin fluoride products:
1. Determine the fluoride content of the drinking water.2. Make sure the child is not receiving significant amounts of fluoride from other medications and swallowed toothpaste.
3. Periodically check to make sure that the child does not develop significant dental fluorosis.
Multi-Vitamin and Fluoride Drops 0.25 mg should be dispensed in the original plastic container, since contact with glass leads to instability and precipitation. (The amount of sodium fluoride in the 50 mL size is well below the maximum to be dispensed at one time according to recommendations of the American Dental Association.)
Important Considerations When Using Dosage Schedule:
- If fluoride level is unknown, drinking water should be tested for fluoride content before supplements are prescribed. For testing of fluoride content, contact the local or state health department.
- All sources of fluoride should be evaluated with a thorough fluoride history.
- Patient exposure to multiple water sources can make proper prescribing complex.
- Ingestion of higher than recommended levels of fluoride by children has been associated with an increase in mild dental fluorosis in developing, unerupted teeth.
- Fluoride supplements require long-term compliance on a daily basis.
- ADVERSE REACTIONS
-
DOSAGE AND ADMINISTRATION
See following chart. May be dropped directly into mouth with dropper; or mixed with cereal, fruit juice or other food.
Fluoride Ion Level in Drinking Water (ppm)* Age <0.3 ppm 0.3-0.6 ppm >0.6 ppm Birth - 6 months None None None 6 mos - 3 years 0.25 mg (1 mL) / day** None None 3 - 6 years 0.50 mg (2 mL) / day 0.25 mg (1 mL) / day None *1.0 ppm = 1 mg/liter ** 2.2 mg sodium fluoride contains 1 mg fluoride ion. - HOW SUPPLIED
- RECOMMENDED STORAGE
-
REFERENCES
1. Brudevoid F, McCann HG: Fluoride and caries control - Mechanism of action, in Nizel AE (ed): The Science of Nutrition and its Application in Clinical Dentistry. Philadelphia, WB Saunders Co, 966, pp 331-347.
2. American Academy of Pediatrics Committee on Nutrition: Fluoride supplementation, Pediatrics 1986;77:758.
3. American Dental Association Council on Dental Therapeutics: Accepted Dental Therapeutics, ed 38, Chicago, 1979, p 321.
4. Hennon DK, Stookey GK, Muhler JC: The clinical anticariogenic effectiveness of supplementary fluoride-vitamin preparations - Results at the end of three years. J Dent Children 1966; 33 January:3-12.
5. Hennon DK, Stookey GK, Muhler JC: The clinical anticariogenic effectiveness of supplementary fluoride-vitamin preparations - Results at the end of four years. J Dent Children 1967; 34\ November;439- 443.
6. Hennon DK, Stookey GK, Muhler JC: The clinical anticariogenic effectiveness of supplementary fluoride-vitamin preparations - Results at the end of five and a half years. Phar and Ther in Dent 1970; 1:1.
7. Hennon DK, Stookey GK, Beiswanger BB: Fluoride-vitamin supplements: Effects on dental caries and fluorosis when used in areas with suboptimum fluoride in the water supply. J Am DentAssoc 1977; 95-965.
Manufactured for: Boca Pharmacal, Inc. Coral Springs, FL 33065 www.bocapharmacal.com 1-800-354-8460 Rev. 05/11
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
MULTI-VITAMIN FLUORIDE DROPS
vitamin a, vitamin c, vitamin d, vitamin e, vitamin b1, vitamin b2, vitamin b12, niacin, vitamin b6, flouride solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:52959-593(NDC:64376-820) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength VITAMIN A (UNII: 81G40H8B0T) (VITAMIN A - UNII:81G40H8B0T) VITAMIN A 1500 [iU] in 1 mL THIAMINE (UNII: X66NSO3N35) (THIAMINE - UNII:X66NSO3N35) THIAMINE 0.5 mg in 1 mL RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN 0.6 mg in 1 mL ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID 35 mg in 1 mL CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL 400 [iU] in 1 mL NIACIN (UNII: 2679MF687A) (NIACIN - UNII:2679MF687A) NIACIN 8 mg in 1 mL PYRIDOXINE (UNII: KV2JZ1BI6Z) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE 0.4 mg in 1 mL CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN 2 ug in 1 mL FLUORIDE ION (UNII: Q80VPU408O) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION 0.25 mg in 1 mL .ALPHA.-TOCOPHEROL SUCCINATE, D- (UNII: LU4B53JYVE) (.ALPHA.-TOCOPHEROL SUCCINATE, D- - UNII:LU4B53JYVE) .ALPHA.-TOCOPHEROL SUCCINATE, D- 5 [iU] in 1 mL Inactive Ingredients Ingredient Name Strength SODIUM HYDROXIDE (UNII: 55X04QC32I) SODIUM BENZOATE (UNII: OJ245FE5EU) WATER (UNII: 059QF0KO0R) POLYSORBATE 80 (UNII: 6OZP39ZG8H) METHYLPARABEN (UNII: A2I8C7HI9T) GLYCERIN (UNII: PDC6A3C0OX) ORANGE OIL (UNII: AKN3KSD11B) FERROUS SULFATE (UNII: 39R4TAN1VT) CHERRY (UNII: BUC5I9595W) CARAMEL (UNII: T9D99G2B1R) Product Characteristics Color BROWN (caramel) Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52959-593-50 50 mL in 1 BOTTLE, DROPPER Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 05/04/2011 Labeler - H.J. Harkins Company, Inc. (147681894) Registrant - Boca Pharmacal, Inc. (170266089) Establishment Name Address ID/FEI Business Operations Sonar Products, Inc. 104283945 MANUFACTURE